Orbis Allan Gray’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$91.5M Buy
3,760,821
+2,013,194
+115% +$55.7M 0.3% 58
2026
Q2
$59.2M Buy
+1,747,627
New +$57.6M 0.2% 65

Other funds holding NAMS

Orbis Allan Gray's NAMS Position: Q3 2026 in Review

Orbis Allan Gray increased its NewAmsterdam Pharma (NAMS) stake by 115% in Q3 2026, buying an estimated $55.7M and bringing the position to 3,760,821 shares worth $91.5M. The position accounts for 0.3% of the portfolio, ranked #58.

Orbis Allan Gray first reported a position in NAMS in Q2 2026 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.

  • Orbis Allan Gray held 3,760,821 shares of NewAmsterdam Pharma worth $91.5M as of Q3 2026.
  • Orbis Allan Gray bought 2,013,194 NewAmsterdam Pharma shares in Q3 2026, an estimated $55.7M.
  • NewAmsterdam Pharma made up 0.3% of Orbis Allan Gray's portfolio in Q3 2026, its #58 holding.
  • Orbis Allan Gray first reported a position in NewAmsterdam Pharma in Q2 2026 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.

Based on Orbis Allan Gray's 13F filing for Q3 2026, filed 16 Nov 2026.